Cite
HARVARD Citation
Belohlavkova, P. et al. (2019). First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. Leukemia research. pp. 67-74. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Belohlavkova, P. et al. (2019). First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. Leukemia research. pp. 67-74. [Online].